32 /100
MEDIUM RISK
Score updated May 30, 2026

EIKN — Eikon Therapeutics, Inc. Dilution Risk Tracker

Track EIKN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EIKN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for EIKN.
🔔 Track EIKN — Get forecast alerts →

💹 Market Data

Market Cap$586.86M
Shares Outstanding54.14M
Float27.52M
Cash$512.18M
Debt$254.83M
Short InterestN/A

🏛 Institutional Holdings

64.2% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track EIKN for full holder detail →

📉 Short Interest

Short Interest3.61M
Days to Cover10.4
% of Float13.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2026
xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track EIKN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking EIKN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for EIKN
📊 EIKN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 EIKN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.